nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—Cisplatin—germ cell cancer	0.517	1	CbGbCtD
Cysteamine—SST—myenteric nerve plexus—germ cell cancer	0.0518	0.185	CbGeAlD
Cysteamine—SST—vagus nerve—germ cell cancer	0.0345	0.123	CbGeAlD
Cysteamine—SST—cranial nerve—germ cell cancer	0.0263	0.0939	CbGeAlD
Cysteamine—SST—pineal body—germ cell cancer	0.0186	0.0663	CbGeAlD
Cysteamine—SST—ganglion—germ cell cancer	0.0133	0.0475	CbGeAlD
Cysteamine—NPY2R—telencephalon—germ cell cancer	0.0132	0.047	CbGeAlD
Cysteamine—SST—blood vessel—germ cell cancer	0.0106	0.0378	CbGeAlD
Cysteamine—NPY2R—head—germ cell cancer	0.00819	0.0293	CbGeAlD
Cysteamine—Gastrointestinal ulcer haemorrhage—Cisplatin—germ cell cancer	0.008	0.0531	CcSEcCtD
Cysteamine—SST—neck—germ cell cancer	0.00758	0.027	CbGeAlD
Cysteamine—Skin striae—Bleomycin—germ cell cancer	0.00655	0.0435	CcSEcCtD
Cysteamine—SST—trigeminal ganglion—germ cell cancer	0.00654	0.0234	CbGeAlD
Cysteamine—SST—embryo—germ cell cancer	0.00632	0.0226	CbGeAlD
Cysteamine—NPY2R—brain—germ cell cancer	0.00594	0.0212	CbGeAlD
Cysteamine—SST—brainstem—germ cell cancer	0.00579	0.0207	CbGeAlD
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—FGF4—germ cell cancer	0.00571	0.109	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00568	0.109	CbGpPWpGaD
Cysteamine—SST—eye—germ cell cancer	0.00564	0.0201	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00547	0.105	CbGpPWpGaD
Cysteamine—Gastrointestinal ulcer—Methotrexate—germ cell cancer	0.00544	0.0361	CcSEcCtD
Cysteamine—SST—telencephalon—germ cell cancer	0.00514	0.0183	CbGeAlD
Cysteamine—SST—decidua—germ cell cancer	0.00487	0.0174	CbGeAlD
Cysteamine—Papilloedema—Cisplatin—germ cell cancer	0.00482	0.032	CcSEcCtD
Cysteamine—MPO—endothelium—germ cell cancer	0.00463	0.0165	CbGeAlD
Cysteamine—Gastrointestinal ulcer haemorrhage—Methotrexate—germ cell cancer	0.00439	0.0291	CcSEcCtD
Cysteamine—MPO—blood vessel—germ cell cancer	0.00427	0.0152	CbGeAlD
Cysteamine—SST—pituitary gland—germ cell cancer	0.00418	0.0149	CbGeAlD
Cysteamine—SST—medulla oblongata—germ cell cancer	0.00404	0.0144	CbGeAlD
Cysteamine—SST—adrenal gland—germ cell cancer	0.00374	0.0133	CbGeAlD
Cysteamine—SST—midbrain—germ cell cancer	0.00369	0.0132	CbGeAlD
Cysteamine—SST—spinal cord—germ cell cancer	0.0036	0.0129	CbGeAlD
Cysteamine—SST—endocrine gland—germ cell cancer	0.00324	0.0116	CbGeAlD
Cysteamine—SST—head—germ cell cancer	0.0032	0.0114	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00303	0.058	CbGpPWpGaD
Cysteamine—SST—cerebellum—germ cell cancer	0.00285	0.0102	CbGeAlD
Cysteamine—Optic neuritis—Cisplatin—germ cell cancer	0.00249	0.0166	CcSEcCtD
Cysteamine—Tubulointerstitial nephritis—Ifosfamide—germ cell cancer	0.00232	0.0154	CcSEcCtD
Cysteamine—SST—brain—germ cell cancer	0.00232	0.00828	CbGeAlD
Cysteamine—Optic neuritis—Etoposide—germ cell cancer	0.00228	0.0152	CcSEcCtD
Cysteamine—SST—lymph node—germ cell cancer	0.00224	0.008	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00223	0.0426	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00214	0.0409	CbGpPWpGaD
Cysteamine—MPO—skin of body—germ cell cancer	0.00197	0.00705	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.00179	0.0342	CbGpPWpGaD
Cysteamine—Appetite absent—Methotrexate—germ cell cancer	0.00169	0.0112	CcSEcCtD
Cysteamine—MPO—pituitary gland—germ cell cancer	0.00168	0.00601	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—AVP—germ cell cancer	0.00153	0.0292	CbGpPWpGaD
Cysteamine—MPO—adrenal gland—germ cell cancer	0.00151	0.00537	CbGeAlD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00149	0.0286	CbGpPWpGaD
Cysteamine—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00148	0.00981	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—AVP—germ cell cancer	0.00146	0.028	CbGpPWpGaD
Cysteamine—MPO—bone marrow—germ cell cancer	0.00146	0.0052	CbGeAlD
Cysteamine—MPO—spinal cord—germ cell cancer	0.00145	0.00518	CbGeAlD
Cysteamine—Lethargy—Dactinomycin—germ cell cancer	0.00144	0.00955	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00143	0.0274	CbGpPWpGaD
Cysteamine—Phosphatase alkaline increased—Etoposide—germ cell cancer	0.00141	0.00933	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—AVP—germ cell cancer	0.0014	0.0268	CbGpPWpGaD
Cysteamine—Encephalopathy—Methotrexate—germ cell cancer	0.00131	0.00871	CcSEcCtD
Cysteamine—MPO—endocrine gland—germ cell cancer	0.00131	0.00466	CbGeAlD
Cysteamine—Liver function test abnormal—Dactinomycin—germ cell cancer	0.0013	0.00864	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.0013	0.0249	CbGpPWpGaD
Cysteamine—Pain in extremity—Ifosfamide—germ cell cancer	0.00129	0.00858	CcSEcCtD
Cysteamine—MPO—head—germ cell cancer	0.00129	0.0046	CbGeAlD
Cysteamine—MPO—testis—germ cell cancer	0.00124	0.00444	CbGeAlD
Cysteamine—MPO—C-MYB transcription factor network—KITLG—germ cell cancer	0.00119	0.0229	CbGpPWpGaD
Cysteamine—Blood alkaline phosphatase increased—Etoposide—germ cell cancer	0.00117	0.00779	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—OXT—germ cell cancer	0.00114	0.0218	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—OXT—germ cell cancer	0.00109	0.0209	CbGpPWpGaD
Cysteamine—Dehydration—Cisplatin—germ cell cancer	0.00104	0.00687	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00102	0.0196	CbGpPWpGaD
Cysteamine—Anaemia—Vinblastine—germ cell cancer	0.000996	0.00661	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000982	0.0188	CbGpPWpGaD
Cysteamine—Renal failure—Ifosfamide—germ cell cancer	0.000978	0.0065	CcSEcCtD
Cysteamine—Leukopenia—Vinblastine—germ cell cancer	0.000964	0.0064	CcSEcCtD
Cysteamine—MPO—brain—germ cell cancer	0.000934	0.00333	CbGeAlD
Cysteamine—Convulsion—Vinblastine—germ cell cancer	0.000934	0.0062	CcSEcCtD
Cysteamine—Bone disorder—Methotrexate—germ cell cancer	0.000932	0.00619	CcSEcCtD
Cysteamine—Hypertension—Vinblastine—germ cell cancer	0.00093	0.00618	CcSEcCtD
Cysteamine—Erythema—Bleomycin—germ cell cancer	0.00091	0.00604	CcSEcCtD
Cysteamine—Discomfort—Vinblastine—germ cell cancer	0.000906	0.00602	CcSEcCtD
Cysteamine—MPO—lymph node—germ cell cancer	0.000902	0.00322	CbGeAlD
Cysteamine—Hallucination—Ifosfamide—germ cell cancer	0.000889	0.0059	CcSEcCtD
Cysteamine—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000882	0.00586	CcSEcCtD
Cysteamine—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000878	0.00583	CcSEcCtD
Cysteamine—Urethral disorder—Ifosfamide—germ cell cancer	0.000876	0.00582	CcSEcCtD
Cysteamine—Erythema—Dactinomycin—germ cell cancer	0.000849	0.00564	CcSEcCtD
Cysteamine—Renal failure—Cisplatin—germ cell cancer	0.000843	0.0056	CcSEcCtD
Cysteamine—Anaemia—Bleomycin—germ cell cancer	0.000841	0.00558	CcSEcCtD
Cysteamine—Anorexia—Vinblastine—germ cell cancer	0.000838	0.00557	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—KIT—germ cell cancer	0.000815	0.0156	CbGpPWpGaD
Cysteamine—Leukopenia—Bleomycin—germ cell cancer	0.000815	0.00541	CcSEcCtD
Cysteamine—Immune system disorder—Ifosfamide—germ cell cancer	0.000807	0.00536	CcSEcCtD
Cysteamine—Anaemia—Dactinomycin—germ cell cancer	0.000784	0.00521	CcSEcCtD
Cysteamine—Mental disorder—Ifosfamide—germ cell cancer	0.000783	0.0052	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—AVP—germ cell cancer	0.00078	0.0149	CbGpPWpGaD
Cysteamine—Erythema—Ifosfamide—germ cell cancer	0.000778	0.00516	CcSEcCtD
Cysteamine—Malnutrition—Ifosfamide—germ cell cancer	0.000778	0.00516	CcSEcCtD
Cysteamine—Renal failure—Etoposide—germ cell cancer	0.000773	0.00513	CcSEcCtD
Cysteamine—Discomfort—Bleomycin—germ cell cancer	0.000765	0.00508	CcSEcCtD
Cysteamine—Decreased appetite—Vinblastine—germ cell cancer	0.000764	0.00508	CcSEcCtD
Cysteamine—Urinary tract disorder—Cisplatin—germ cell cancer	0.000761	0.00505	CcSEcCtD
Cysteamine—Leukopenia—Dactinomycin—germ cell cancer	0.00076	0.00504	CcSEcCtD
Cysteamine—Connective tissue disorder—Cisplatin—germ cell cancer	0.000757	0.00503	CcSEcCtD
Cysteamine—Urethral disorder—Cisplatin—germ cell cancer	0.000755	0.00501	CcSEcCtD
Cysteamine—Constipation—Vinblastine—germ cell cancer	0.000752	0.00499	CcSEcCtD
Cysteamine—Confusional state—Bleomycin—germ cell cancer	0.000749	0.00497	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—AVP—germ cell cancer	0.000748	0.0143	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Bleomycin—germ cell cancer	0.000743	0.00493	CcSEcCtD
Cysteamine—Feeling abnormal—Vinblastine—germ cell cancer	0.000725	0.00481	CcSEcCtD
Cysteamine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000719	0.00477	CcSEcCtD
Cysteamine—Anaemia—Ifosfamide—germ cell cancer	0.000719	0.00477	CcSEcCtD
Cysteamine—Agitation—Ifosfamide—germ cell cancer	0.000715	0.00475	CcSEcCtD
Cysteamine—Discomfort—Dactinomycin—germ cell cancer	0.000714	0.00474	CcSEcCtD
Cysteamine—Anorexia—Bleomycin—germ cell cancer	0.000708	0.0047	CcSEcCtD
Cysteamine—Urinary tract disorder—Etoposide—germ cell cancer	0.000697	0.00463	CcSEcCtD
Cysteamine—Leukopenia—Ifosfamide—germ cell cancer	0.000696	0.00462	CcSEcCtD
Cysteamine—Immune system disorder—Cisplatin—germ cell cancer	0.000696	0.00462	CcSEcCtD
Cysteamine—Abdominal pain—Vinblastine—germ cell cancer	0.000695	0.00462	CcSEcCtD
Cysteamine—Urethral disorder—Etoposide—germ cell cancer	0.000692	0.00459	CcSEcCtD
Cysteamine—Convulsion—Ifosfamide—germ cell cancer	0.000674	0.00447	CcSEcCtD
Cysteamine—Hypertension—Ifosfamide—germ cell cancer	0.000671	0.00446	CcSEcCtD
Cysteamine—Malnutrition—Cisplatin—germ cell cancer	0.00067	0.00445	CcSEcCtD
Cysteamine—Erythema—Cisplatin—germ cell cancer	0.00067	0.00445	CcSEcCtD
Cysteamine—Anorexia—Dactinomycin—germ cell cancer	0.00066	0.00438	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000658	0.00437	CcSEcCtD
Cysteamine—Discomfort—Ifosfamide—germ cell cancer	0.000654	0.00434	CcSEcCtD
Cysteamine—Hypersensitivity—Vinblastine—germ cell cancer	0.000648	0.0043	CcSEcCtD
Cysteamine—Decreased appetite—Bleomycin—germ cell cancer	0.000646	0.00429	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—OXT—germ cell cancer	0.000643	0.0123	CbGpPWpGaD
Cysteamine—Confusional state—Ifosfamide—germ cell cancer	0.00064	0.00425	CcSEcCtD
Cysteamine—Immune system disorder—Etoposide—germ cell cancer	0.000637	0.00423	CcSEcCtD
Cysteamine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000635	0.00421	CcSEcCtD
Cysteamine—Asthenia—Vinblastine—germ cell cancer	0.000631	0.00419	CcSEcCtD
Cysteamine—Tremor—Cisplatin—germ cell cancer	0.000628	0.00417	CcSEcCtD
Cysteamine—Lethargy—Methotrexate—germ cell cancer	0.000623	0.00414	CcSEcCtD
Cysteamine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000622	0.00413	CcSEcCtD
Cysteamine—Anaemia—Cisplatin—germ cell cancer	0.00062	0.00411	CcSEcCtD
Cysteamine—Skin disorder—Ifosfamide—germ cell cancer	0.000617	0.00409	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—OXT—germ cell cancer	0.000616	0.0118	CbGpPWpGaD
Cysteamine—Feeling abnormal—Bleomycin—germ cell cancer	0.000612	0.00406	CcSEcCtD
Cysteamine—Anorexia—Ifosfamide—germ cell cancer	0.000605	0.00402	CcSEcCtD
Cysteamine—Decreased appetite—Dactinomycin—germ cell cancer	0.000602	0.004	CcSEcCtD
Cysteamine—Diarrhoea—Vinblastine—germ cell cancer	0.000602	0.00399	CcSEcCtD
Cysteamine—Leukopenia—Cisplatin—germ cell cancer	0.0006	0.00399	CcSEcCtD
Cysteamine—Fatigue—Dactinomycin—germ cell cancer	0.000597	0.00397	CcSEcCtD
Cysteamine—Urticaria—Bleomycin—germ cell cancer	0.00059	0.00392	CcSEcCtD
Cysteamine—Body temperature increased—Bleomycin—germ cell cancer	0.000587	0.0039	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—OXT—germ cell cancer	0.000584	0.0112	CbGpPWpGaD
Cysteamine—Dizziness—Vinblastine—germ cell cancer	0.000581	0.00386	CcSEcCtD
Cysteamine—Convulsion—Cisplatin—germ cell cancer	0.000581	0.00386	CcSEcCtD
Cysteamine—Mood swings—Methotrexate—germ cell cancer	0.000579	0.00384	CcSEcCtD
Cysteamine—Ataxia—Methotrexate—germ cell cancer	0.000574	0.00381	CcSEcCtD
Cysteamine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000571	0.00379	CcSEcCtD
Cysteamine—Anaemia—Etoposide—germ cell cancer	0.000568	0.00377	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000567	0.00376	CcSEcCtD
Cysteamine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000566	0.00376	CcSEcCtD
Cysteamine—Somnolence—Ifosfamide—germ cell cancer	0.000564	0.00375	CcSEcCtD
Cysteamine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000564	0.00375	CcSEcCtD
Cysteamine—Discomfort—Cisplatin—germ cell cancer	0.000564	0.00374	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—OXT—germ cell cancer	0.00056	0.0107	CbGpPWpGaD
Cysteamine—Vomiting—Vinblastine—germ cell cancer	0.000559	0.00371	CcSEcCtD
Cysteamine—Decreased appetite—Ifosfamide—germ cell cancer	0.000552	0.00366	CcSEcCtD
Cysteamine—Headache—Vinblastine—germ cell cancer	0.000551	0.00366	CcSEcCtD
Cysteamine—Leukopenia—Etoposide—germ cell cancer	0.00055	0.00365	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000548	0.00364	CcSEcCtD
Cysteamine—Abdominal pain—Dactinomycin—germ cell cancer	0.000548	0.00364	CcSEcCtD
Cysteamine—Body temperature increased—Dactinomycin—germ cell cancer	0.000548	0.00364	CcSEcCtD
Cysteamine—Fatigue—Ifosfamide—germ cell cancer	0.000547	0.00363	CcSEcCtD
Cysteamine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000547	0.00363	CcSEcCtD
Cysteamine—Hypersensitivity—Bleomycin—germ cell cancer	0.000547	0.00363	CcSEcCtD
Cysteamine—Constipation—Ifosfamide—germ cell cancer	0.000543	0.0036	CcSEcCtD
Cysteamine—Nervous system disorder—Cisplatin—germ cell cancer	0.000537	0.00356	CcSEcCtD
Cysteamine—Asthenia—Bleomycin—germ cell cancer	0.000533	0.00354	CcSEcCtD
Cysteamine—Convulsion—Etoposide—germ cell cancer	0.000532	0.00353	CcSEcCtD
Cysteamine—Skin disorder—Cisplatin—germ cell cancer	0.000532	0.00353	CcSEcCtD
Cysteamine—Hypertension—Etoposide—germ cell cancer	0.00053	0.00352	CcSEcCtD
Cysteamine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000523	0.00347	CcSEcCtD
Cysteamine—Nausea—Vinblastine—germ cell cancer	0.000522	0.00347	CcSEcCtD
Cysteamine—Anorexia—Cisplatin—germ cell cancer	0.000522	0.00346	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000519	0.00345	CcSEcCtD
Cysteamine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000519	0.00345	CcSEcCtD
Cysteamine—Discomfort—Etoposide—germ cell cancer	0.000517	0.00343	CcSEcCtD
Cysteamine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00051	0.00339	CcSEcCtD
Cysteamine—Confusional state—Etoposide—germ cell cancer	0.000505	0.00336	CcSEcCtD
Cysteamine—Urticaria—Ifosfamide—germ cell cancer	0.000504	0.00335	CcSEcCtD
Cysteamine—Abdominal pain—Ifosfamide—germ cell cancer	0.000502	0.00333	CcSEcCtD
Cysteamine—Body temperature increased—Ifosfamide—germ cell cancer	0.000502	0.00333	CcSEcCtD
Cysteamine—Anaphylactic shock—Etoposide—germ cell cancer	0.000501	0.00333	CcSEcCtD
Cysteamine—Asthenia—Dactinomycin—germ cell cancer	0.000497	0.0033	CcSEcCtD
Cysteamine—Skin disorder—Etoposide—germ cell cancer	0.000487	0.00323	CcSEcCtD
Cysteamine—Anorexia—Etoposide—germ cell cancer	0.000478	0.00317	CcSEcCtD
Cysteamine—Decreased appetite—Cisplatin—germ cell cancer	0.000476	0.00316	CcSEcCtD
Cysteamine—Diarrhoea—Dactinomycin—germ cell cancer	0.000474	0.00315	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000472	0.00314	CcSEcCtD
Cysteamine—Vomiting—Bleomycin—germ cell cancer	0.000472	0.00314	CcSEcCtD
Cysteamine—Rash—Bleomycin—germ cell cancer	0.000468	0.00311	CcSEcCtD
Cysteamine—Dermatitis—Bleomycin—germ cell cancer	0.000468	0.00311	CcSEcCtD
Cysteamine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000468	0.00311	CcSEcCtD
Cysteamine—Renal failure—Methotrexate—germ cell cancer	0.000463	0.00307	CcSEcCtD
Cysteamine—Asthenia—Ifosfamide—germ cell cancer	0.000455	0.00302	CcSEcCtD
Cysteamine—Feeling abnormal—Cisplatin—germ cell cancer	0.000451	0.00299	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—MYC—germ cell cancer	0.000449	0.00858	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—germ cell cancer	0.000447	0.00855	CbGpPWpGaD
Cysteamine—Somnolence—Etoposide—germ cell cancer	0.000446	0.00296	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—germ cell cancer	0.000441	0.00845	CbGpPWpGaD
Cysteamine—Nausea—Bleomycin—germ cell cancer	0.000441	0.00293	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—AVP—germ cell cancer	0.000441	0.00843	CbGpPWpGaD
Cysteamine—Vomiting—Dactinomycin—germ cell cancer	0.00044	0.00292	CcSEcCtD
Cysteamine—Rash—Dactinomycin—germ cell cancer	0.000437	0.0029	CcSEcCtD
Cysteamine—Decreased appetite—Etoposide—germ cell cancer	0.000436	0.00289	CcSEcCtD
Cysteamine—Diarrhoea—Ifosfamide—germ cell cancer	0.000434	0.00288	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000433	0.00287	CcSEcCtD
Cysteamine—Body temperature increased—Cisplatin—germ cell cancer	0.000433	0.00287	CcSEcCtD
Cysteamine—Fatigue—Etoposide—germ cell cancer	0.000432	0.00287	CcSEcCtD
Cysteamine—Constipation—Etoposide—germ cell cancer	0.000429	0.00285	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—AVP—germ cell cancer	0.000422	0.00809	CbGpPWpGaD
Cysteamine—Dizziness—Ifosfamide—germ cell cancer	0.00042	0.00279	CcSEcCtD
Cysteamine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000417	0.00277	CcSEcCtD
Cysteamine—Urethral disorder—Methotrexate—germ cell cancer	0.000414	0.00275	CcSEcCtD
Cysteamine—Feeling abnormal—Etoposide—germ cell cancer	0.000413	0.00274	CcSEcCtD
Cysteamine—Nausea—Dactinomycin—germ cell cancer	0.000411	0.00273	CcSEcCtD
Cysteamine—Gastrointestinal pain—Etoposide—germ cell cancer	0.00041	0.00272	CcSEcCtD
Cysteamine—Vomiting—Ifosfamide—germ cell cancer	0.000404	0.00268	CcSEcCtD
Cysteamine—Hypersensitivity—Cisplatin—germ cell cancer	0.000403	0.00268	CcSEcCtD
Cysteamine—Rash—Ifosfamide—germ cell cancer	0.0004	0.00266	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—AVP—germ cell cancer	0.0004	0.00766	CbGpPWpGaD
Cysteamine—Dermatitis—Ifosfamide—germ cell cancer	0.0004	0.00265	CcSEcCtD
Cysteamine—Urticaria—Etoposide—germ cell cancer	0.000398	0.00264	CcSEcCtD
Cysteamine—Abdominal pain—Etoposide—germ cell cancer	0.000396	0.00263	CcSEcCtD
Cysteamine—Body temperature increased—Etoposide—germ cell cancer	0.000396	0.00263	CcSEcCtD
Cysteamine—Asthenia—Cisplatin—germ cell cancer	0.000393	0.00261	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—AVP—germ cell cancer	0.000384	0.00734	CbGpPWpGaD
Cysteamine—Immune system disorder—Methotrexate—germ cell cancer	0.000382	0.00253	CcSEcCtD
Cysteamine—Nausea—Ifosfamide—germ cell cancer	0.000377	0.0025	CcSEcCtD
Cysteamine—Diarrhoea—Cisplatin—germ cell cancer	0.000374	0.00249	CcSEcCtD
Cysteamine—Mental disorder—Methotrexate—germ cell cancer	0.00037	0.00246	CcSEcCtD
Cysteamine—Hypersensitivity—Etoposide—germ cell cancer	0.000369	0.00245	CcSEcCtD
Cysteamine—Malnutrition—Methotrexate—germ cell cancer	0.000368	0.00244	CcSEcCtD
Cysteamine—Erythema—Methotrexate—germ cell cancer	0.000368	0.00244	CcSEcCtD
Cysteamine—Asthenia—Etoposide—germ cell cancer	0.00036	0.00239	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—germ cell cancer	0.000352	0.00674	CbGpPWpGaD
Cysteamine—Vomiting—Cisplatin—germ cell cancer	0.000348	0.00231	CcSEcCtD
Cysteamine—Rash—Cisplatin—germ cell cancer	0.000345	0.00229	CcSEcCtD
Cysteamine—SST—Signaling Pathways—OXT—germ cell cancer	0.000345	0.0066	CbGpPWpGaD
Cysteamine—Dermatitis—Cisplatin—germ cell cancer	0.000345	0.00229	CcSEcCtD
Cysteamine—Diarrhoea—Etoposide—germ cell cancer	0.000343	0.00228	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—germ cell cancer	0.00034	0.00226	CcSEcCtD
Cysteamine—Dizziness—Etoposide—germ cell cancer	0.000332	0.0022	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—OXT—germ cell cancer	0.000331	0.00633	CbGpPWpGaD
Cysteamine—Leukopenia—Methotrexate—germ cell cancer	0.000329	0.00219	CcSEcCtD
Cysteamine—Nausea—Cisplatin—germ cell cancer	0.000325	0.00216	CcSEcCtD
Cysteamine—Convulsion—Methotrexate—germ cell cancer	0.000319	0.00212	CcSEcCtD
Cysteamine—Vomiting—Etoposide—germ cell cancer	0.000319	0.00212	CcSEcCtD
Cysteamine—Rash—Etoposide—germ cell cancer	0.000316	0.0021	CcSEcCtD
Cysteamine—Dermatitis—Etoposide—germ cell cancer	0.000316	0.0021	CcSEcCtD
Cysteamine—Headache—Etoposide—germ cell cancer	0.000314	0.00209	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000311	0.00207	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—germ cell cancer	0.000309	0.00205	CcSEcCtD
Cysteamine—Confusional state—Methotrexate—germ cell cancer	0.000303	0.00201	CcSEcCtD
Cysteamine—Anaphylactic shock—Methotrexate—germ cell cancer	0.0003	0.00199	CcSEcCtD
Cysteamine—Nausea—Etoposide—germ cell cancer	0.000298	0.00198	CcSEcCtD
Cysteamine—Nervous system disorder—Methotrexate—germ cell cancer	0.000294	0.00196	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF4—germ cell cancer	0.000294	0.00563	CbGpPWpGaD
Cysteamine—Skin disorder—Methotrexate—germ cell cancer	0.000292	0.00194	CcSEcCtD
Cysteamine—Anorexia—Methotrexate—germ cell cancer	0.000286	0.0019	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGF4—germ cell cancer	0.000282	0.0054	CbGpPWpGaD
Cysteamine—Somnolence—Methotrexate—germ cell cancer	0.000267	0.00177	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—germ cell cancer	0.000264	0.00176	CcSEcCtD
Cysteamine—SST—Signaling Pathways—H2AFZ—germ cell cancer	0.000263	0.00503	CbGpPWpGaD
Cysteamine—Decreased appetite—Methotrexate—germ cell cancer	0.000261	0.00173	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000259	0.00172	CcSEcCtD
Cysteamine—Fatigue—Methotrexate—germ cell cancer	0.000259	0.00172	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—H2AFZ—germ cell cancer	0.000252	0.00482	CbGpPWpGaD
Cysteamine—Feeling abnormal—Methotrexate—germ cell cancer	0.000247	0.00164	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000246	0.00163	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KITLG—germ cell cancer	0.000242	0.00463	CbGpPWpGaD
Cysteamine—Urticaria—Methotrexate—germ cell cancer	0.000239	0.00158	CcSEcCtD
Cysteamine—Abdominal pain—Methotrexate—germ cell cancer	0.000237	0.00158	CcSEcCtD
Cysteamine—Body temperature increased—Methotrexate—germ cell cancer	0.000237	0.00158	CcSEcCtD
Cysteamine—SST—Signaling Pathways—AVP—germ cell cancer	0.000236	0.00452	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KITLG—germ cell cancer	0.000232	0.00444	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AVP—germ cell cancer	0.000227	0.00434	CbGpPWpGaD
Cysteamine—Hypersensitivity—Methotrexate—germ cell cancer	0.000221	0.00147	CcSEcCtD
Cysteamine—Asthenia—Methotrexate—germ cell cancer	0.000215	0.00143	CcSEcCtD
Cysteamine—Diarrhoea—Methotrexate—germ cell cancer	0.000205	0.00136	CcSEcCtD
Cysteamine—Dizziness—Methotrexate—germ cell cancer	0.000199	0.00132	CcSEcCtD
Cysteamine—Vomiting—Methotrexate—germ cell cancer	0.000191	0.00127	CcSEcCtD
Cysteamine—Rash—Methotrexate—germ cell cancer	0.000189	0.00126	CcSEcCtD
Cysteamine—Dermatitis—Methotrexate—germ cell cancer	0.000189	0.00126	CcSEcCtD
Cysteamine—Headache—Methotrexate—germ cell cancer	0.000188	0.00125	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGFR3—germ cell cancer	0.00018	0.00344	CbGpPWpGaD
Cysteamine—Nausea—Methotrexate—germ cell cancer	0.000178	0.00118	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGFR3—germ cell cancer	0.000172	0.0033	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KIT—germ cell cancer	0.000165	0.00316	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KIT—germ cell cancer	0.000158	0.00303	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—germ cell cancer	0.000121	0.00231	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—germ cell cancer	0.000116	0.00222	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—germ cell cancer	9.08e-05	0.00174	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—germ cell cancer	8.71e-05	0.00167	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—germ cell cancer	7.46e-05	0.00143	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—germ cell cancer	7.15e-05	0.00137	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—germ cell cancer	7.13e-05	0.00136	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—germ cell cancer	6.84e-05	0.00131	CbGpPWpGaD
